Axiogenesis Cor.At mESC cardiomyocytes

Monday, 21 June, 2010 | Supplied by: Lonza Australia Pty Ltd


Embryonic stem cell-derived cardiomyocytes have many of the phenotypic properties of primary cardiomyocytes and show great potential to model human diseases. The Cor.At cells are cardiomyocytes derived from transgenic mouse embryonic stem cells and are available cryopreserved in ampoules.

The cells are highly pure with ampoules containing 99% cardiomyocytes. Their minimal lot-to-lot variation is claimed to give consistent performance and the standardised production process ensures stable supply.

The cardiomyocytes are a good predictive model with relevant background including all important ion channels well characterised.

They are suitable for applications including: electrophysiology (patch clamp, microelectrode arrays, Ca2+ flux analysis), non-arrhythmic cardiotoxicity (cell viability, label-free analysis, troponin release), drug profiling and target discovery (hypertrophy, gene expression, transfection, tissue engineering).

Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences anti-α-Tubulin, recombinant antibodies

AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed...

Advanced Analytical Technology High Sensitivity Fragment Analysis Kits for cfDNA quality control

Advanced Analytical Technology's line of High Sensitivity Fragment Analysis Kits for its...

EpiGentek CRISPR/Cas9 SaCas9 Monoclonal Antibody [6H4]

EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus...

  • All content Copyright © 2018 Westwick-Farrow Pty Ltd